Oligomerix Revenue and Competitors
Estimated Revenue & Valuation
- Oligomerix's estimated annual revenue is currently $2.5M per year.
- Oligomerix's estimated revenue per employee is $155,000
Employee Data
- Oligomerix has 16 Employees.
- Oligomerix grew their employee count by 7% last year.
Oligomerix's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO and Head, Discovery & Strategy | Reveal Email/Phone |
2 | CFO and Chief Operating Officer | Reveal Email/Phone |
3 | Sr. Director Chemistry | Reveal Email/Phone |
4 | Director, Chief Commercial Officer | Reveal Email/Phone |
5 | Chief Scientific Officer, Co-Founder | Reveal Email/Phone |
6 | Lab Manager | Reveal Email/Phone |
7 | Scientist, Discovery | Reveal Email/Phone |
8 | Analytical Chemist | Reveal Email/Phone |
9 | Research Associate | Reveal Email/Phone |
10 | President & Head Development & Operations | Reveal Email/Phone |
Oligomerix Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.6M | 4 | 0% | N/A | N/A |
#2 | $3.7M | 24 | 41% | $44M | N/A |
#3 | $6.2M | 40 | -7% | N/A | N/A |
#4 | $42M | 271 | -1% | N/A | N/A |
#5 | $12.7M | 82 | 0% | $10M | N/A |
#6 | $2.5M | 16 | 0% | N/A | N/A |
#7 | $7.5M | 45 | 0% | $51.6M | N/A |
#8 | $0.2M | 1 | -50% | N/A | N/A |
#9 | $4.3M | 26 | -16% | $3.3M | N/A |
#10 | $3.7M | 24 | 4% | N/A | N/A |
What Is Oligomerix?
Oligomerix is an emerging biotechnology company focused on developing disease-modifying therapeutics for Alzheimer's disease and related dementias by targeting tau self-association. The company's drug discovery platform has identified a pipeline of novel small molecule inhibitors, with preclinical IND-enabling studies in progress for the lead program. Oligomerix's small molecule approach blocks the formation of all tau aggregates by targeting tau self-association, known as the beginning of the aggregation cascade, whereas other companies have focused on targeting large tau aggregates formed downstream. The NYC-based company is located at the Ullmann Research Center for Health Sciences within the Albert Einstein College of Medicine. Follow us on Twitter @oligomerix
keywords:N/AN/A
Total Funding
16
Number of Employees
$2.5M
Revenue (est)
7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2M | 16 | -16% | N/A |
#2 | $1.4M | 16 | 0% | N/A |
#3 | $2M | 16 | -11% | N/A |
#4 | $1.5M | 17 | 6% | N/A |
#5 | $2.5M | 18 | 0% | N/A |